PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:31 AM ET

Sponsor Check › Person

KF
No photo found yet (own website and image search run after this page is viewed)

Keith Flaherty

Named as an officer, director or promoter on SEC Form D filings · MA · Aug 20, 2019 → May 15, 2025

4deals (issuers)
$272.1Mreported sold
90investors
8Form D filings
2019–2025years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:44 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Keith Flaherty is listed as an executive officer, director, and promoter on 8 SEC Form D filings by 4 issuers between Aug 2019 and May 2025: Scorpion Therapeutics, Inc. (Boston, MA — biotechnology — 2020–2024; $147M reported sold to 38 investors), Checkmate Pharmaceuticals, Inc. (Cambridge, MA — biotechnology — 2019–2020; $85.1M reported sold to 17 investors), Antares Therapeutics, Inc. (Boston, MA — biotechnology — 2025; $40M reported sold to 35 investors) and C-REVEAL THERAPEUTICS LLC (Pembroke, MA — biotechnology — 2020).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer, director, and promoter, over about 6 years. Across those companies the filings report $272.1M sold in total.

Listed alongside Alan Fuhrman (4 shared filings), Arthur Krieg (4 shared filings), Barry Labinger (4 shared filings), Charles Yon (4 shared filings), Corey Goodman (4 shared filings) and 29 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Keith. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 8 public filings for Keith Flaherty and found 6 differences: Form D filed 17 days after the first sale; 4 offerings have no amendment in the last 12 months and may still be open; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Keith Flaherty has not run yet — it is joining a line of 18,047 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:44 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Keith Flaherty..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

Keith B. Flaherty and Jessica Flaherty closed
United States Bankruptcy Court, D. Vermont · No. 03-11696 · Filed Nov 10, 2003 · Closed Apr 5, 2004
Role of Keith B. Flaherty and Jessica Flaherty: Debtor · Outcome: Case closed 2004-04-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 5 people with this name in Form D filings; court in VT (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:44 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

6 differences found between the filings for Keith Flaherty (compared 8 filings on Oct 24, 2026)

Note · Nov 20, 2020 – Dec 7, 2020

Form D filed 17 days after the first sale — Scorpion Therapeutics, Inc.

The filing says the first sale was Nov 20, 2020. The Form D was filed Dec 7, 2020 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jun 9, 2020 – May 15, 2025

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Antares Therapeutics, Inc. (latest filing May 15, 2025) · No amendment in the last 12 months on an offering that may still be open — Scorpion Therapeutics, Inc. (latest filing Jul 16, 2024) · No amendment in the last 12 months on an offering that may still be open — Scorpion Therapeutics, Inc. (latest filing Dec 7, 2020) · No amendment in the last 12 months on an offering that may still be open — Checkmate Pharmaceuticals, Inc. (latest filing Jun 18, 2020)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · May 11, 2018 – Nov 22, 2024

Same name, different state: "Keith Flaherty" (MI) is a separate record

This page covers filings where the address state is MA. A separate record, "Keith Flaherty" with address state MI, is listed on 3 filings — most recently by Strata Oncology, Inc. (Nov 22, 2024). Both records have filings in the same period (Aug 20, 2019 to Nov 22, 2024).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Aug 4, 2020 – Aug 31, 2020

Same name, different state: "Keith Flaherty" (CA) is a separate record

This page covers filings where the address state is MA. A separate record, "Keith Flaherty" with address state CA, is listed on 2 filings — most recently by Kinnate Biopharma Inc. (Aug 31, 2020). Both records have filings in the same period (Aug 4, 2020 to Aug 31, 2020).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · May 12, 2014

Same name, different state: "Keith Flaherty" (CT) is a separate record

This page covers filings where the address state is MA. A separate record, "Keith Flaherty" with address state CT, is listed on 1 filing — most recently by Loxo Oncology, Inc. (May 12, 2014). The two records do not overlap in time: this page runs Aug 20, 2019 to May 15, 2025; the other has one filing dated May 12, 2014.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Nov 27, 2013

Same name, different state: "Keith Flaherty" (CO) is a separate record

This page covers filings where the address state is MA. A separate record, "Keith Flaherty" with address state CO, is listed on 1 filing — most recently by Clovis Oncology, Inc. (Nov 27, 2013). The two records do not overlap in time: this page runs Aug 20, 2019 to May 15, 2025; the other has one filing dated Nov 27, 2013.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 7 offerings reports sales commissions totalling $159,250; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
May 15, 2025 D
Antares Therapeutics, Inc.
File 021-546316
$0$0$0None listed on this filingEDGAR ↗
Jul 16, 2024 D
Scorpion Therapeutics, Inc.
File 021-518868
$0$0$0None listed on this filingEDGAR ↗
Dec 18, 2020 D
C-REVEAL THERAPEUTICS LLC
File 021-383635
$159,250 (est.)$0$0 (est.)LIVINGSTON SECURITIES, LLC BrokerCheck CRD 147364 ↗
via LIVINGSTON SECURITIES, LLC (CRD 147364 ↗)
EDGAR ↗
Dec 7, 2020 D
Scorpion Therapeutics, Inc.
File 021-382478
$0$0$0None listed on this filingEDGAR ↗
Jun 18, 2020 D
Checkmate Pharmaceuticals, Inc.
File 021-369265
$0$0$0None listed on this filingEDGAR ↗
Apr 24, 2020 D
Checkmate Pharmaceuticals, Inc.
File 021-365710
$0$0$0None listed on this filingEDGAR ↗
Jan 28, 2020 D/A
Checkmate Pharmaceuticals, Inc.
File 021-347004
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Keith Flaherty on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Antares Therapeutics, Inc.

Boston, MA · May 15, 2025
  • May 15, 2025 · D · $30,000,000 sold of $136,650,000 · 35 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $40M from 35 investors (29% of the $136.7M target) as of the latest filing. Keith is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Scorpion Therapeutics, Inc.

Boston, MA · Dec 7, 2020 → Jul 16, 2024 · 2 filings
  • Jul 16, 2024 · D · $125,694,186 sold of $150,000,002 · 38 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 7, 2020 · D · $146,999,977 sold of Indefinite · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $147M from 38 investors (98% of the $150M target) as of the latest filing. Keith is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

C-REVEAL THERAPEUTICS LLC

Pembroke, MA · Dec 18, 2020
  • Dec 18, 2020 · D · $0 sold of $3,250,000 · 0 investors · min. $5,000 · role: Director, Promoter, Executive Officer (There is no clarification needed.) EDGAR ↗

No sales reported yet as of the latest filing. Keith is listed as director, promoter, executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(c) (163 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Checkmate Pharmaceuticals, Inc.

Cambridge, MA · Aug 20, 2019 → Jun 18, 2020 · 4 filings
  • Jun 18, 2020 · D · $85,083,280 sold of $100,083,274 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 24, 2020 · D · $10,000,000 sold of $10,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 28, 2020 · D/A · $15,999,999 sold of $15,999,999 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 20, 2019 · D · $7,999,996 sold of $15,999,999 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $85.1M from 17 investors (85% of the $100.1M target) as of the latest filing. Keith is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (4)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Keith Flaherty — CO, 1 issuer, Nov 27, 2013 → Nov 27, 2013 · no shared issuer
  • Keith Flaherty — CT, 1 issuer, May 12, 2014 → May 12, 2014 · no shared issuer
  • Keith Flaherty — MI, 1 issuer, May 11, 2018 → Nov 22, 2024 · no shared issuer
  • Keith Flaherty — CA, 1 issuer, Aug 4, 2020 → Aug 31, 2020 · no shared issuer

People around Keith 34

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Corey Goodman

Director · 4 shared filings (1 issuer) · also on 20 other issuers

Corey Goodman is on 21 issuers in total — a repeat sponsor. Their page lists every one.

AK
No photo found yet (own website and image search run after this page is viewed)
Person

Arthur Krieg

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Powell

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

CY
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Yon

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Karen Brennan

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

BL
No photo found yet (own website and image search run after this page is viewed)
Person

Barry Labinger

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

AF
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Fuhrman

Director · 4 shared filings (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Shelley Chu

Director · 3 shared filings (2 issuers) · also on 7 other issuers

Shelley Chu is on 9 issuers in total — a repeat sponsor. Their page lists every one.

RW
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Weisskoff

Director · 3 shared filings (1 issuer) · also on 17 other issuers

Robert Weisskoff is on 18 issuers in total — a repeat sponsor. Their page lists every one.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

Jean-Francois Formela

Director · 3 shared filings (2 issuers) · also on 24 other issuers

Jean-Francois Formela is on 26 issuers in total — a repeat sponsor. Their page lists every one.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Lieber

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

JW
No photo found yet (own website and image search run after this page is viewed)
Person

James Wooldridge

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

KC
No photo found yet (own website and image search run after this page is viewed)
Person

Kleem Chaudhary

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Colabuono

Director · 3 shared filings (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

BP
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Piper

Executive Officer · 2 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

AF
No photo found yet (own website and image search run after this page is viewed)
Person

Adam Friedman

Executive Officer, Director · 2 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

JA
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Albers

Director · 2 shared filings (2 issuers) · also on 3 other issuers

Jeffrey Albers is on 5 issuers in total — a repeat sponsor. Their page lists every one.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Arjun Goyal

Director · 2 shared filings (1 issuer) · also on 9 other issuers

Arjun Goyal is on 10 issuers in total — a repeat sponsor. Their page lists every one.

OS
No photo found yet (own website and image search run after this page is viewed)
Person

Otello Stampacchia

Director · 2 shared filings (1 issuer) · also on 6 other issuers

Otello Stampacchia is on 7 issuers in total — a repeat sponsor. Their page lists every one.

AF
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Fedder

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

GG
No photo found yet (own website and image search run after this page is viewed)
Person

Gary D. Glick

Executive Officer, Director · 1 shared filing (1 issuer) · also on 7 other issuers

Gary D. Glick is on 8 issuers in total — a repeat sponsor. Their page lists every one.

ON
No photo found yet (own website and image search run after this page is viewed)
Person

Oleg Nodelman

Director · 1 shared filing (1 issuer) · also on 11 other issuers

Oleg Nodelman is on 12 issuers in total — a repeat sponsor. Their page lists every one.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jon Lieber

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

BA
No photo found yet (own website and image search run after this page is viewed)
Person

Ben Auspitz

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Ben Auspitz is on 6 issuers in total — a repeat sponsor. Their page lists every one.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Joseph Campisi, Jr.

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Cobbold

Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Cyril Benes

Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

TH
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Haag

Director, Promoter, Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

Darrin Stuart

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

EJ
No photo found yet (own website and image search run after this page is viewed)
Person

Erica Jackson

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

AV
No photo found yet (own website and image search run after this page is viewed)
Person

Amanda Valentino

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Saurabh Saha

Director · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Chao

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Menelas N. Pangalos

Director · 1 shared filing (1 issuer)

Listed on the same filings as Keith Flaherty. Their page shows their other deals.

The team behind the deals

Same business address

17 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

4 Regulation Crowdfunding filings — tap to see each filing
SourceFiledFormIssuerAmount offered (as reported)Amount sold (as reported)Matched on
EDGAR ↗Feb 8, 2022
File 020-27353
Regulation Crowdfunding progress update (Form C-U)
Progress update filed · deadline May 1, 2021
C-REVEAL THERAPEUTICS LLC
Pembroke, MA
$10,000 target · $1,070,000 maximum
via NetCapital Funding Portal Inc. (CRD 283596 · FINRA funding portals ↗)
Not reported on this formsigner name on this filing (Keith Flaherty) + listed as a related person on Form D filings of the same issuer (CIK 1834759) · 85%
EDGAR ↗Apr 13, 2021
File 020-27353
Regulation Crowdfunding offering — amendment (Form C/A)
Amendment filed · deadline May 1, 2021
C-REVEAL THERAPEUTICS LLC
Pembroke, MA
$10,000 target · $1,070,000 maximum
via NetCapital Funding Portal Inc. (CRD 283596 · FINRA funding portals ↗)
Not reported on this formsigner name on this filing (Keith Flaherty) + listed as a related person on Form D filings of the same issuer (CIK 1834759) · 85%
EDGAR ↗Feb 16, 2021
File 020-27353
Regulation Crowdfunding offering — amendment (Form C/A)
Amendment filed · deadline Apr 16, 2021
C-REVEAL THERAPEUTICS LLC
Pembroke, MA
$10,000 target · $1,070,000 maximum
via NetCapital Funding Portal Inc. (CRD 283596 · FINRA funding portals ↗)
Not reported on this formsigner name on this filing (Keith Flaherty) + listed as a related person on Form D filings of the same issuer (CIK 1834759) · 85%
EDGAR ↗Dec 18, 2020
File 020-27353
Regulation Crowdfunding offering (Form C)
Offering filed · deadline Feb 17, 2021
C-REVEAL THERAPEUTICS LLC
Pembroke, MA
$10,000 target · $1,070,000 maximum
via NetCapital Funding Portal Inc. (CRD 283596 · FINRA funding portals ↗)
Not reported on this formsigner name on this filing (Keith Flaherty) + listed as a related person on Form D filings of the same issuer (CIK 1834759) · 85%

Amounts are as reported by the issuer on the form; Regulation Crowdfunding forms report a target and maximum, not sales. Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Keith Flaherty by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Keith Flaherty is listed on, as found in their SEC filings (Form C, Reg A, Form ADV, EDGAR profile) or on the sponsor's own site; none belongs to the person unless the sponsor's site says so. Checked Oct 24, 2026.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Found on the sponsor's own site

crev.bio ↗ found on C-REVEAL THERAPEUTICS LLC (crev.bio — Form C 0001669191-22-000111 (issuer website as filed))

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Keith Flaherty appears on a new Form D, or when a court case or SEC action is matched to them. See plans →